<?xml version="1.0" encoding="UTF-8"?>
<p id="p0800">A number other VLP-based vaccines are in clinical trials. These include the anti-influenza A M2-HBcAg VLP vaccine (
 <xref rid="bib6" ref-type="bibr">Clarke et al., 1987</xref>), two antimalarial vaccine nicotine-Qβ VLPs (
 <xref rid="bib30" ref-type="bibr">Maurer et al., 2005</xref>), and an anti-AngIIQβ VLP. The VLP production in mammalian cell lines and Baculo cell lines of viruses infecting humans and other animals is summarized in 
 <xref rid="t0035" ref-type="table">Table 14.6</xref> .
</p>
